Arkolith/Insider Trading/COYA/Form 4

Lee Ann

DirectorCoya Therapeutics, Inc. (COYA) · full profile →Form 4 · filed Jan 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2023Buy(P)10K——10K
Jan 3, 2023Conversion(C)6K$4.00$26K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2023Conversion(C)0—$06K
Jan 3, 2023Buy(P)5K——9K

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-000226) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML